| 靶点: |
IC50: 86 nM (Arginase 1), 296 nM (Arginase 2) |
| 体内研究: |
Numidargistat (100 mg/kg, p.o., twice per day) increases the number of tumor-infiltrating cytotoxic cells and decreases myeloid cells in mice. Numidargistat in combination with PD-L1 blockade or gemcitabine inhibits tumor growth in mice bearing CT26 cancer cells. |
| 参考文献: |
1. Steggerda SM, et al. Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment. J Immunother Cancer. 2017 Dec 19;5(1):101. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.483 ml |
17.414 ml |
34.829 ml |
| 5 mM |
0.697 ml |
3.483 ml |
6.966 ml |
| 10 mM |
0.348 ml |
1.741 ml |
3.483 ml |
| 50 mM |
0.07 ml |
0.348 ml |
0.697 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |